MedPath

Aquacel Versus Iodoform Gauze for Filling Abscess Cavity Following Incision and Drainage

Phase 2
Completed
Conditions
Abscess
Cellulitis
Interventions
Device: Type of dressing - Aquacel
Device: Type of dressing - Iodoform
Registration Number
NCT00984022
Lead Sponsor
Valleywise Health
Brief Summary

This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess.

Detailed Description

The large increase in the incidence of skin and soft tissue infections cause by methicillin resistant staphylococcus aureus (MRSA) has produced a corresponding increase in the number of ED patients presenting with abscesses that require incision and drainage. This study compares Aquacel against routine Iodoform packing for packing abscess cavities after incision and drainage. It is hypothesized that Aquacel will produce speedier healing of the abscess. More effective abscess healing will reduce the need for oral antibiotic coverage, which will in turn reduce the potential for drug resistance caused by indiscriminate use of oral antibiotics.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
92
Inclusion Criteria
  • presenting to Maricopa Medical Center ED with cutaneous abscess requiring incision and drainage
Exclusion Criteria
  • known sensitivity to Aquacel
  • pregnant, nursing, or expecting to become pregnant
  • incarcerated patient
  • prior treatment of same abscess with incision and drainage
  • multiple abscesses
  • immunodeficiency
  • facial abscess
  • suspected osteomyelitis or septic arthritis
  • diabetic foot, decubitis, or ischaemic ulcers
  • unable to provide informed consent or assent

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Aquacel dressingType of dressing - AquacelAquacel dressing for cutaneous abscess
Iodoform dressingType of dressing - IodoformIodoform dressing for cutaneous abscess
Primary Outcome Measures
NameTimeMethod
Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Abscess2 weeks

Participants were assessed to see whether or not the surface area of the abscess was reduced by at least 30%, and the number of such participants is reported.

Secondary Outcome Measures
NameTimeMethod
Change in Patient Rating of PainBaseline and 2 weeks

Change in mean pain score based on patient self-report, using Wong-Baker FACES pain rating scale. Scale ranges from 0 to 5, where 5 means the worst pain possible and 0 means no pain at all.

Number of Participants Who Experienced a 30% or Greater Reduction in Surface Area of Cellulitis.2 weeks

Participants were assessed to see whether or not the surface area of the cellulitis was reduced by at least 30% and the number of such participants was reported.

Trial Locations

Locations (1)

Maricopa Integrated Health System

🇺🇸

Phoenix, Arizona, United States

© Copyright 2025. All Rights Reserved by MedPath